Premium
Risk of systemic adverse events after botulinum neurotoxin A treatment in cerebral palsy
Author(s) -
Papavasiliou Antigone S
Publication year - 2018
Publication title -
developmental medicine and child neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.658
H-Index - 143
eISSN - 1469-8749
pISSN - 0012-1622
DOI - 10.1111/dmcn.14025
Subject(s) - botulinum neurotoxin , cerebral palsy , medicine , adverse effect , physical medicine and rehabilitation , biology , toxin , biochemistry
This commentary is on the original article by Paget et al. on pages 1172–1177 of this issue.